Bone Biologics Corporation (BBLG)
USD 0.71
(-17.43%)
USD 0.71
(-17.43%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.94 Million USD | -1385.86% |
| 2022 | 695.93 Thousand USD | 143.21% |
| 2021 | -1.61 Million USD | 11.73% |
| 2020 | -1.82 Million USD | 46.72% |
| 2019 | -3.42 Million USD | 22.7% |
| 2018 | -4.43 Million USD | 37.17% |
| 2017 | -7.05 Million USD | 66.47% |
| 2016 | -21.02 Million USD | -51.54% |
| 2015 | -13.87 Million USD | -213.64% |
| 2014 | -4.42 Million USD | -308.83% |
| 2013 | -1.08 Million USD | -151137.69% |
| 2012 | -715.57 USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -13.34 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -865.97 Thousand USD | 44.13% |
| 2024 Q2 | -783.73 Thousand USD | 9.5% |
| 2023 Q1 | -4.27 Million USD | -239.05% |
| 2023 Q4 | -1.54 Million USD | 19.26% |
| 2023 Q3 | -1.91 Million USD | -8.5% |
| 2023 FY | -8.94 Million USD | -1385.86% |
| 2023 Q2 | -1.76 Million USD | 58.59% |
| 2022 Q4 | 3.07 Million USD | 351.99% |
| 2022 Q2 | -469.3 Thousand USD | 31.94% |
| 2022 Q1 | -689.49 Thousand USD | -287.93% |
| 2022 FY | 695.93 Thousand USD | 143.21% |
| 2022 Q3 | -1.21 Million USD | -159.81% |
| 2021 Q2 | -491.89 Thousand USD | -13.93% |
| 2021 Q3 | -509.3 Thousand USD | -3.54% |
| 2021 Q4 | -177.73 Thousand USD | 65.1% |
| 2021 FY | -1.61 Million USD | 11.73% |
| 2021 Q1 | -431.74 Thousand USD | 4.84% |
| 2020 Q2 | -380.03 Thousand USD | 36.33% |
| 2020 Q4 | -453.71 Thousand USD | -15.14% |
| 2020 FY | -1.82 Million USD | 46.72% |
| 2020 Q1 | -596.9 Thousand USD | -12.38% |
| 2020 Q3 | -394.04 Thousand USD | -3.69% |
| 2019 Q3 | -561.41 Thousand USD | 39.34% |
| 2019 Q2 | -925.55 Thousand USD | 34.2% |
| 2019 Q1 | -1.4 Million USD | 4.35% |
| 2019 FY | -3.42 Million USD | 22.7% |
| 2019 Q4 | -531.14 Thousand USD | 5.39% |
| 2018 Q3 | -241.74 Thousand USD | 80.86% |
| 2018 FY | -4.43 Million USD | 37.17% |
| 2018 Q4 | -1.47 Million USD | -508.37% |
| 2018 Q2 | -1.26 Million USD | 13.15% |
| 2018 Q1 | -1.45 Million USD | 37.15% |
| 2017 Q1 | -3.07 Million USD | 36.99% |
| 2017 FY | -7.05 Million USD | 66.47% |
| 2017 Q4 | -2.31 Million USD | 8.42% |
| 2017 Q3 | -2.52 Million USD | -348.69% |
| 2017 Q2 | 1.01 Million USD | 133.06% |
| 2016 Q2 | -4.8 Million USD | 31.21% |
| 2016 FY | -21.02 Million USD | -51.54% |
| 2016 Q4 | -4.87 Million USD | -11.59% |
| 2016 Q1 | -6.97 Million USD | 12.57% |
| 2016 Q3 | -4.37 Million USD | 8.91% |
| 2015 Q4 | -7.98 Million USD | -137.32% |
| 2015 Q3 | -3.36 Million USD | -277.53% |
| 2015 Q2 | -890.8 Thousand USD | 45.74% |
| 2015 Q1 | -1.64 Million USD | -54.84% |
| 2015 FY | -13.87 Million USD | -213.64% |
| 2014 Q4 | -1.06 Million USD | 59.42% |
| 2014 FY | -4.42 Million USD | -308.83% |
| 2014 Q3 | -2.61 Million USD | -511.1% |
| 2014 Q2 | -427.56 Thousand USD | -32.11% |
| 2014 Q1 | -323.64 Thousand USD | 9.72% |
| 2013 FY | -1.08 Million USD | -151137.69% |
| 2013 Q3 | -238.22 Thousand USD | 22.26% |
| 2013 Q2 | -306.45 Thousand USD | -26.25% |
| 2013 Q4 | -358.5 Thousand USD | -50.49% |
| 2013 Q1 | -242.73 Thousand USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | -715.57 USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | -13.34 Thousand USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 85.477% |
| BrainsWay Ltd. | -4.19 Million USD | -113.217% |
| Cerus Corporation | -37.48 Million USD | 76.13% |
| Envoy Medical, Inc. | -29.9 Million USD | 70.079% |
| electroCore, Inc. | -18.83 Million USD | 52.486% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -1.116% |
| IceCure Medical Ltd | -14.65 Million USD | 38.925% |
| Inogen, Inc. | -102.44 Million USD | 91.265% |
| OrthoPediatrics Corp. | -20.97 Million USD | 57.334% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 83.009% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 34.896% |
| MaxCyte, Inc. | -37.92 Million USD | 76.403% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 24.544% |
| Nexalin Technology, Inc. | -4.64 Million USD | -92.499% |
| Orthofix Medical Inc. | -151.39 Million USD | 94.089% |
| PAVmed Inc | -64.17 Million USD | 86.056% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 82.944% |
| RxSight, Inc. | -48.6 Million USD | 81.59% |
| Sight Sciences, Inc. | -55.54 Million USD | 83.89% |
| SI-BONE, Inc. | -43.33 Million USD | 79.35% |
| TELA Bio, Inc. | -46.66 Million USD | 80.823% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 81.932% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 34.118% |
| Acutus Medical, Inc. | -81.66 Million USD | 89.042% |
| Talis Biomedical Corporation | -62 Million USD | 85.568% |
| Spectral AI, Inc. | -20.85 Million USD | 57.089% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 85.276% |
| CVRx, Inc. | -41.19 Million USD | 78.279% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1497.811% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 18.316% |
| Bioventus Inc. | -156.23 Million USD | 94.272% |
| Venus Concept Inc. | -37.25 Million USD | 75.977% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 84.842% |
| LivaNova PLC | 17.54 Million USD | 151.002% |
| 908 Devices Inc. | -36.39 Million USD | 75.415% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 95.205% |
| Nemaura Medical Inc. | -14.14 Million USD | 36.73% |
| NeuroPace, Inc. | -32.95 Million USD | 72.846% |
| LENSAR, Inc. | -14.38 Million USD | 37.783% |
| Apyx Medical Corporation | -18.71 Million USD | 52.179% |
| Cutera, Inc. | -162.83 Million USD | 94.504% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 17.371% |
| BioSig Technologies, Inc. | -29.04 Million USD | 69.186% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 89.175% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 59.488% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 113.21% |
| Axonics, Inc. | -6.08 Million USD | -46.99% |
| Outset Medical, Inc. | -172.79 Million USD | 94.821% |
| IRIDEX Corporation | -9.57 Million USD | 6.492% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 91.55% |
| IRadimed Corporation | 17.19 Million USD | 152.049% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -8.548% |
| INVO Bioscience, Inc. | -8.03 Million USD | -11.377% |
| Telesis Bio, Inc. | -47.72 Million USD | 81.249% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 187.364% |
| Varex Imaging Corporation | -47.7 Million USD | 81.24% |
| Quipt Home Medical Corp. | -2.78 Million USD | -221.434% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 20.709% |
| Pulmonx Corporation | -60.84 Million USD | 85.292% |
| Dynatronics Corporation | -2.69 Million USD | -231.715% |
| Modular Medical, Inc. | -17.47 Million USD | 48.777% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 21.413% |
| Semler Scientific, Inc. | 20.58 Million USD | 143.476% |
| InMode Ltd. | 197.91 Million USD | 104.521% |
| Bruker Corporation | 427.2 Million USD | 102.095% |
| Cytosorbents Corporation | -28.5 Million USD | 68.609% |
| DexCom, Inc. | 541.5 Million USD | 101.653% |
| Align Technology, Inc. | 445.05 Million USD | 102.011% |
| Viveve Medical, Inc. | -22.02 Million USD | 59.374% |
| ZimVie Inc. | -393.28 Million USD | 97.725% |
| Movano Inc. | -29.28 Million USD | 69.441% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 26.336% |
| Nexalin Technology, Inc. | -4.64 Million USD | -92.499% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1497.811% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 95.98% |
| Profound Medical Corp. | -28.56 Million USD | 68.677% |
| Insulet Corporation | 206.3 Million USD | 104.338% |
| enVVeno Medical Corporation | -23.51 Million USD | 61.946% |
| Surmodics, Inc. | -11.54 Million USD | 22.468% |
| iCAD, Inc. | -4.84 Million USD | -84.624% |
| Nuwellis, Inc. | -20.2 Million USD | 55.719% |
| Biotricity, Inc. | -14.09 Million USD | 36.508% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 92.749% |
| Aethlon Medical, Inc. | -12.2 Million USD | 26.699% |
| InspireMD, Inc. | -19.91 Million USD | 55.068% |
| PAVmed Inc. | -64.17 Million USD | 86.056% |
| BIOLASE, Inc. | -20.63 Million USD | 56.627% |
| Beyond Air, Inc. | -60.24 Million USD | 85.145% |
| FONAR Corporation | 10.56 Million USD | 184.682% |
| AxoGen, Inc. | -21.71 Million USD | 58.792% |
| Vivani Medical, Inc. | -25.65 Million USD | 65.115% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 131.383% |
| Inari Medical, Inc. | -1.63 Million USD | -446.988% |
| UFP Technologies, Inc. | 44.92 Million USD | 119.92% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -74.36% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -35.48% |
| Tenon Medical, Inc. | -15.58 Million USD | 42.566% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 41.989% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 74.673% |
| AdaptHealth Corp. | -678.89 Million USD | 98.682% |
| Sintx Technologies, Inc. | -8.25 Million USD | -8.351% |
| NanoVibronix, Inc. | -3.71 Million USD | -141.141% |
| Quanterix Corporation | -32.33 Million USD | 72.324% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 20.709% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1945.099% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 97.083% |
| TransMedics Group, Inc. | -25.02 Million USD | 64.245% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 59.568% |
| NeuroMetrix, Inc. | -6.52 Million USD | -37.051% |
| Hyperfine, Inc. | -44.23 Million USD | 79.771% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 88.601% |
| Biomerica, Inc. | -5.97 Million USD | -49.694% |
| AVITA Medical, Inc. | -39.16 Million USD | 77.153% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 10.098% |
| Silk Road Medical, Inc | -55.74 Million USD | 83.946% |